Lupin, Zydus Lifesciences and PVP Ventures to see some action today

Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Paliperidone Extended-Release Tablets 1.5 mg, 3 mg, 6 mg, and 9 mg, to market a generic equivalent of Invega Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg, of Janssen Research and Development, LLC. The product will be manufactured at Lupin’s facility in Goa, India. Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of $152 million in the U.S. (IQVIA MAT March 2022).

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) single-dose vials (US RLD: Vimpat). Lacosamide Injection is used to treat partial-onset seizures. It is also used with other medicines to treat primary generalized tonic-clonic seizures. It acts on the Central Nervous System (CNS) to reduce the number and severity of seizures.

PVP Ventures has entered into a definitive agreement with Casagrand Builders to develop residential community on portion of its land parcel situated at Perambur, Chennai on a joint development basis and have also executed a definitive sale agreement to sell a portion of its land parcel.

PNB Housing Finance is planning to borrow funds and issue of non-convertible debentures (NCDs) on a private placement basis aggregating to Rs 12,000 crore in one or more tranches. The shareholders' approval is being sought in the 34th annual general meeting (AGM) on July 26, 2022 for the same.

Infibeam Avenues is all set to unveil CCAvenue Mobile App ? World’s most advanced Omni?channel Payment Platform with a new built?in CCAvenue TapPay - a revolutionary SoftPoS solution. On July 7, 2022, the company will be formally launching the CCAvenue Mobile App with the TapPay feature, which will be a game?changer in the Indian market as the innovative technology converts any NFC?enabled Android phone into a POS terminal.

IRB Hapur Moradabad Tollway, the Special Purpose Vehicle of IRB Infrastructure Developers, which is now a part of IRB Infrastructure Trust - Private InvIT, has received completion certificate from NHAI for its Hapur to Moradabad six laning highway project in the State of Uttar Pradesh. Consequently, the Company can now collect toll at higher tariffs, increasing by approximately 65% over existing toll tariffs.

ITD Cementation India has received Letter of Acceptance for construction of Wharf and Approach Trestle Works from Bharat Mumbai Container Terminals (BMCT) at Jawaharlal Nehru Port worth over Rs 700 crore plus applicable taxes. The company secured orders worth over Rs 6,000 crore in Q1 FY23.